Frontiers in Oncology | Hematologic Malignancies

Case Report

Accepted on 25 Jun 2025

Treatment of relapsed or refractory Hodgkin's lymphoma with lenalidomide combined with PD-1 monoclonal antibody: a case report and literature review

in Hematologic Malignancies

HongJuan Dong
Rui Wang
Guangxun Gao
Lu Cheng
Shirong Ma
Li Zhu
Jing Zhao

Frontiers in Oncology

doi 10.3389/fonc.2025.1632039

Case Report

Accepted on 24 Jun 2025

A Novel t(15;17)(q24;q11.2) Translocation Involving NF1::SCAMP5 Fusion in a Patient with Myeloproliferative neoplasms: a case report

in Hematologic Malignancies

Yuying Chang
Yakun Chen
Weiwei Zhao
Guomin Shen
Sujuan Guo
Wei Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1600963

Case Report

Accepted on 24 Jun 2025

Case Report: Myelodysplastic/Myeloproliferative Neoplasm with Concurrent SF3B1, ASXL1, JAK2 and CBL Mutations and <15% Bone Marrow Ringed Sideroblasts

in Hematologic Malignancies

Yifan Wang
Shengyu Jin

Frontiers in Oncology

doi 10.3389/fonc.2025.1622820

Case Report

Accepted on 24 Jun 2025

Isolated Relapse of Multiple Myeloma in the Central Nervous System Post Autologous Hematopoietic Stem Cell Transplantation: A Case Report and Literature Review

in Hematologic Malignancies

Ying Zhou
Shen Qian
Jie Zhang
Zhu Li
Jiang Qi
Xiaobing Miao

Frontiers in Oncology

doi 10.3389/fonc.2025.1628297

Review

Published on 24 Jun 2025

Advances in the role of the IGF signaling system in myelodysplastic syndromes and acute myeloid leukemia

in Hematologic Malignancies

Yifan Wang
Xinyu Dong
Shandong Tao
Qiuni Chen
Yue Chen
Lijuan Zhang
Yuye Shi
Zhengmei He
Liang Yu
Chunling Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1540426

347 views

Case Report

Published on 24 Jun 2025

Case Report: Sequential lymphomas: may HLA system play a role in this uncommon phenomenon?

in Hematologic Malignancies

Evgenia Verrou
Ioanna Diamanti
Asimina Fylaktou
Aikaterini Daiou
Dimitra Dalampira
Xanthippi Dimitriadou
Vassiliki Tara
Elissavet Karadrakonti
Theodora Triantafyllou
Aggeliki Sevastoudi

Frontiers in Oncology

doi 10.3389/fonc.2025.1586454

254 views

Correction

Published on 24 Jun 2025

Correction: The dark side of stemness – the role of hematopoietic stem cells in development of blood malignancies

in Hematologic Malignancies

Jadwiga Filipek-Gorzała
Patrycja Kwiecińska
Agata Szade
Krzysztof Szade

Frontiers in Oncology

doi 10.3389/fonc.2025.1633832

307 views

Mini Review

Accepted on 23 Jun 2025

Philadelphia Chromosome-Positive Mixed-Phenotype Acute Leukemia: A Case Report and Literature Review

in Hematologic Malignancies

Liqing Yang
Meijuan Huang
Yuanzhong Chen
Yong Wu

Frontiers in Oncology

doi 10.3389/fonc.2025.1623528

Review

Published on 23 Jun 2025

Cancer associated fibroblasts in tumors: focusing on solid tumors and hematological malignancies

in Hematologic Malignancies

Chengyun Pan
Lin Zheng
Jishi Wang

Frontiers in Oncology

doi 10.3389/fonc.2025.1596947

406 views

Case Report

Published on 20 Jun 2025

Case Report: Unveiling the role of genetic abnormalities in myelomatous pleural effusion: a case of IgG lambda-type multiple myeloma

in Hematologic Malignancies

Shuangyan Chen
Lanfang Yan
Yinjuan Mo
Daoyin Zhou
Yan Chen

Frontiers in Oncology

doi 10.3389/fonc.2025.1554956

273 views

Original Research

Accepted on 19 Jun 2025

ZFAS1/STAT3 axis modulates imatinib resistance of chronic myeloid leukemia cells through glucose metabolism reprogramming

in Hematologic Malignancies

Yanqiu Han
Lan Yang

Frontiers in Oncology

doi 10.3389/fonc.2025.1603060

173 views

Original Research

Accepted on 19 Jun 2025

Long-Term Endocrine Outcomes and Quality of Life in Paediatric and Young Chronic Myeloid Leukaemia Patients on Tyrosine Kinase Inhibitor Therapy: A Prospective Study from India

in Hematologic Malignancies

Rajiv Mohan
Chitrakshi Nagpal
Swasthik Upadhya
Akash Kumar
Rajesh Khadgawat
SAMEER BAKHSHI
Deepam Pushpam

Frontiers in Oncology

doi 10.3389/fonc.2025.1598104

136 views

Correction

Published on 19 Jun 2025

Correction: Efficacy and safety of pegylated interferon in the treatment of JAK2V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study

in Hematologic Malignancies

Long Chang
Wen-Xin Li
Hao Cai
Jian Li
Ming-Hui Duan

Frontiers in Oncology

doi 10.3389/fonc.2025.1641150

268 views

Original Research

Accepted on 18 Jun 2025

Observations on seasonal occurrence in lymphomas with proven or presumed infectious etiology

in Hematologic Malignancies

Ioannis Anagnostopoulos
Viktoria Buck
Elena Gerhard-Hartmann
Alberto Zamò
Andreas Rosenwald
Mathias Rosenfeldt
Korinna Jöhrens

Frontiers in Oncology

doi 10.3389/fonc.2025.1586441

100 views

Original Research

Published on 18 Jun 2025

Retrospective analysis of HIV-associated lymphomas: insights from a single Romanian center over 15 years

in Hematologic Malignancies

Monica-Daniela Padurariu-Covit
Iulia Chiscop
Cristian Gutu
Anca-Adriana Arbune
Elena Niculet
Manuela Arbune

Frontiers in Oncology

doi 10.3389/fonc.2025.1569433

278 views

Original Research

Published on 18 Jun 2025

Subcutaneous administration of isatuximab in patients with multiple myeloma by an on-body delivery system: results of a nurse survey

in Hematologic Malignancies

Nuria Sánchez Avello
Paula Calvo Pajares
Paul Cordero
Florence Suzan
Connie Barlas

Frontiers in Oncology

doi 10.3389/fonc.2025.1547108

555 views